Oncogenic Transformation Induced by Membrane-Targeted Akt2 and Akt3
Total Page：16
File Type：pdf, Size：1020Kb
Oncogene (2001) 20, 4419 ± 4423 ã 2001 Nature Publishing Group All rights reserved 0950 ± 9232/01 $15.00 www.nature.com/onc Oncogenic transformation induced by membrane-targeted Akt2 and Akt3 Ines Mende1,3, Scott Malstrom2, Philip N Tsichlis2, Peter K Vogt*,1 and Masahiro Aoki1 1Department of Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, California CA 92037, USA; 2Kimmel Cancer Center, Thomas Jeerson University, Philadelphia, Pennsylvania PA 19107, USA The kinases Akt2, Akt3 and their myristylated variants, v-P3k induces oncogenic transformation of chicken Myr-Akt2 and Myr-Akt3 were expressed by the RCAS embryo ®broblasts (CEF) in culture and hemangiosar- vector in chicken embryo ®broblasts (CEF). Myr-Akt2 comas in chickens (Chang et al., 1997). The transform- and Myr-Akt3 were strongly oncogenic, inducing multi- ing activity of the P3k proteins is routed through the layered foci of transformed cells. In contrast, wild-type serine-threonine kinase Akt1 (protein kinase Ba), Akt2 and Akt3 were only poorly transforming, their because dominant negative Akt1 interferes with P3k- eciencies of focus formation were more than 100-fold induced transformation (Aoki et al., 1998). The akt1 lower; foci appeared later and showed less multilayering. gene was originally isolated as the oncogene of the Addition of the myristylation signal not only enhanced murine lymphomagenic retrovirus AKT8 (Bellacosa et oncogenic potential but also increased kinase activities. al., 1991). Cellular Akt1 binds with its plekstrin Myr-Akt2 and Myr-Akt3 also induced hemangiosarco- homology (PH) domain to the product of PI3K, D3- mas in the animal, whereas wild type Akt2 and Akt3 PPI, and thus is translocated to the plasma membrane. were not oncogenic in vivo. Furthermore, Akt2, driven by At this location, the protein kinases PDK1 and PDK2 the lck (lymphocyte speci®c kinase) promoter in activate Akt1 by phosphorylation of threonine 308 and transgenic mice, induced lymphomas. The oncogenic serine 473 (Alessi and Cohen, 1998; Chan et al., 1999; eects of Akt2 and Akt3 described here are indis- Coer et al., 1998; Datta et al., 1999). Constitutively tinguishable from those of Akt1. The downstream targets activated and membrane-targeted Akt1 causes focus relevant to oncogenic transformation are therefore formation in CEF and hemangiosarcomas in chickens probably shared by the three Akt kinases. Oncogene identical to the tumors induced by P3k (Aoki et al., (2001) 20, 4419 ± 4423. 1998). The oncogenic activity of the PI3K-Akt path- way is also manifest in human cancer. P110a Keywords: Akt; transformation; serine/threonine kinase (PIK110CA) is ampli®ed and overexpressed in ovarian cancers (Shayesteh et al., 1999). Akt1 is ampli®ed in gastric cancer (Staal, 1987). The function of a negative Signals controlled by PI 3-kinase (PI3K) aect diverse regulator of PI3K and Akt signals, PTEN, is lost in cellular functions including response to growth factors, several types of human tumors including glioblastomas dierentiation, and cell survival (Alessi and Downes, and prostate cancer. This loss of PTEN function leads 1998; Fruman et al., 1998; Shepherd et al., 1998; to high levels of D3-PPI and activation of Akt1 (Ali et Wymann and Pirola, 1998). Oncoproteins of the al., 1999; Cantley and Neel, 1999; Di Cristofano and receptor tyrosine kinase and Src families as well as Pandol®, 2000; Maehama and Dixon, 1999). polyoma middle T antigen activate PI3K through In addition to akt1, there are two related genes in association with the regulatory subunit of PI3K, p85, mammalian genomes, akt2 and akt3. These genes code suggesting a role of PI3K in the actions of these for the Akt2 and Akt3 kinases which show a high proteins (Fukui and Hanafusa, 1989; Hu et al., 1992; degree of sequence homology in their catalytic and PH Peles et al., 1992; Reith et al., 1991; Whitman et al., domains to Akt1 but diverge from Akt1 in other 1985). The Ras oncoprotein can activate PI3K by domains. The two regulatory phosphorylation sites binding to the catalytic subunit directly (Rodriguez- that correspond to threonine 308 and serine 473 of ONCOGENOMICS Viciana et al., 1994, 1996). We previously showed that Akt1 are conserved, and Akt2 and Akt3 also transduce the oncoprotein v-P3k of the avian retroviruses ASV PI3K signals (Altomare et al., 1998; Brodbeck et al., 16 and ASV 8905 codes for the catalytic subunit of 1999; Liu et al., 1998; Masure et al., 1999; Meier et al., PI3K, p110a (Chang et al., 1997; Aoki et al., 2000). 1997; Nakatani et al., 1999a). For both Akt2 and Akt3 there are data suggesting a role in human cancer. Akt2 is ampli®ed and overexpressed in ovarian cancer, breast cancer and pancreatic cancer and Akt3 is *Correspondence: PK Vogt, 10550 N. Torrey Pines Rd., BCC-239, overexpressed in breast and prostate cancer (Bellacosa La Jolla, CA 92037, USA et al., 1995; Cheng et al., 1992, 1996; Miwa et al., 1996; 3 Current address: Universitatsklinikum Essen, Virchowstrasse 173, Nakatani et al., 1999b; Ruggeri et al., 1998). In this 45122 Essen, Germany Received 29 November 2000; revised 20 March 2001; accepted 26 communication, we describe oncogenic transformation March 2001 by Akt2 and Akt3 in experimental systems. The in vitro Neoplastic transformation by Akt2 and Akt3 I Mende et al 4420 transformation assays have obvious utility in screens transforming, about as inecient in focus formation for Akt antagonists. as non-myristylated Akt1 (Table 1). Foci induced by Akt2 (of murine origin) and Akt3 (from rat) were R-Akt2 or R-Akt3 took about 3 weeks to develop and cloned with an HA tag in the avian retroviral showed signi®cantly reduced multilayering. Rare in- expression vector RCAS to yield the constructs R- stances of highly transformed foci in R-Akt2 or R- Akt2 and R-Akt3 (Aoki et al., 1998; Hughes et al., Akt3-infected cultures probably resulted from muta- 1987). Two additional constructs expressed the same tions acquired during retroviral replication of the tagged Akt2 or Akt3 proteins but with the myristyla- constructs. As was shown in a previous study, such tion signal of the c-Src kinase added at the amino mutations occur during RCAS replication and can termini (R-Myr-Akt2 and R-Myr-Akt3). The pre- greatly enhance focus formation mediated by a cellular viously described RCAS constructs expressing Akt1 insert in RCAS (Aoki et al., 2000). Oncogenicity of and myristylated Akt1 (R-Akt1 and R-Myr-Akt1) non-myristylated Akt2 was observed previously by served as controls (Figure 1) (Aoki et al., 1998). another group using NIH3T3 cells (Cheng et al., 1997). Separate CEF cultures were transfected with these The apparent disagreement with our results may be constructs, and supernatant growth medium containing explained by the dierence in the host cells used in the infectious RCAS virus with the respective inserts was two studies. Western blots with anti HA epitope used in assays for focus formation on CEF. R-Myr- antibody detected high levels of all Akt proteins in Akt2 and R-Myr-Akt3 were strongly transforming, infected CEF (Figure 3a). The vestigial transforming inducing foci of multilayered cells within one week as activity of R-Akt2 or R-Akt3 was therefore not caused eciently as R-Myr-Akt1 (Figure 2, Table 1). In by insucient protein expression. Kinase activities contrast, the constructs expressing the wild-type were determined by immune complex kinase assays kinases, R-Akt2 and R-Akt3 were only weakly using anti HA antibody for immunoprecipitation and Figure 1 Schematic representation of the Akt constructs used in this study. The pleckstrin homology (PH) domain, protein kinase domain, the two regulatory phosphorylation sites, the myristylation signal, and the HA epitope tag are indicated. Constructs of Akt1 and the Myr-Akt1 mutant were described previously. Akt2, and Myr-Akt2 with the myristylation signal of c-Src proteins were subcloned into the avian retroviral vector RCAS.S® via the adapter vector pBSFI (Aoki et al., 1998). The incomplete carboxyl terminal sequences of the rat akt3 cDNA (Konishi et al., 1995) was reconstructed by PCR with a degenerate primer 5'- GCTCTCTAGATTATTC(T/C)CGTCC(A/G)CTTGCAGAGTAG-3' and the internal primer 5'-CAGGGCTCTTGATAAAG- GATCC-3' using rat brain phage cDNA library (lZAP, Stratagene) as a template (Brodbeck et al., 1999; Masure et al., 1999; Nakatani et al., 1999a). After con®rming the sequences, the wild-type and the myristylated version of Akt3 were subcloned into RCAS.S® Oncogene Neoplastic transformation by Akt2 and Akt3 I Mende et al 4421 a b Figure 3 Expression and in vitro kinase activity of the three Akt Figure 2 Transformation of CEF induced by Akt constructs. proteins. (a) Western blot analysis of the Akt proteins. Cells were Fertilized chicken eggs were obtained from SPAFAS. Primary lysed in Akt lysis buer supplemented with 1 mM microcystin CEF cultures, focus assays and DNA transfections using DMSO- (Calbiochem) (Aoki et al., 1998). Lysates containing 40 mgof polybrene method were described previously (Aoki et al., 1998). protein were separated by SDS ± PAGE and transferred to an Assay plates were evaluated after staining with crystal violet. Immobilon-P membrane (Millipore). The membrane was probed Tests for tumor formation in young chickens followed published with anti HA monoclonal antibody HA-11 (BabCo) followed by procedures (Aoki et al., 1998). Cell culture supernatants of horseradish peroxidase conjugated secondary antibody (Amer- transfected, RCAS construct-releasing CEF were serially diluted sham). Akt proteins were visualized by incubation with a and added to fresh secondary cultures of CEF in 35 mm plates. chemiluminescent substrate (Renaissance Plus, NEN). (b) Immune The cultures were overlaid with nutrient agar for 3 weeks and complex kinase assay. The Akt proteins were immunoprecipitated stained with crystal violet (Aoki et al., 2000). See Table 1 for the from the lysates containing 80 mg of protein with anti HA titer of individual constructs antibody and protein G sepharose beads (Pharmacia).